20-163
SDS Lysis Buffer - for use in ChIP Assay
For use in Chromatin Immunoprecipitation assays.
Synonym(s):
ChIP Lysis Buffer, SDS Lysis Buffer
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
41116012
eCl@ss:
32160405
NACRES:
NA.41
Recommended Products
Application
For use in Chromatin Immunoprecipitation assays.
Research Category
All
All
Physical form
1% SDS, 10mM EDTA and 50mM Tris, pH 8.1
Storage and Stability
1 year at room temperature
Legal Information
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Chromatin immunoprecipitation from dorsal root ganglia tissue following axonal injury.
Elisa Floriddia,Tuan Nguyen,Simone Di Giovanni
Journal of Visualized Experiments null
Lishan Guo et al.
Molecular medicine reports, 21(2), 909-917 (2019-12-04)
Upregulation of fetal hemoglobin expression can alleviate the severity of β‑thalassaemia. This study aimed to investigate the effects of Oridonin (ORI, a diterpenoid compound) on γ‑globin expression in human erythroid precursor cells and the potential underlying mechanisms. Erythroid precursor cells
Liang Xu et al.
Cancer letters, 482, 74-89 (2020-04-20)
Distant metastasis is the major cause of short survival in ccRCC patients. However, the development of effective therapies for metastatic ccRCC is limited. Herein, we reported that ETV4 was selected from among 150 relevant genes with in vivo evidence of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service